Clinical Trial Update: Pharmacokinetics/ Pharmacodynamics and Safety of DA-4001 in Healthy Male Subjects With Androgenic Alopecia [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetics/pharmacodynamics and safety study of DA-4001 in healthy male volunteers with androgenetic alopecia; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Androgenetic Alopecia

Drugs mentioned

• DA-4001

Snippet

Sponsor: Dong-A ST Co., Ltd. | Conditions: Androgenic Alopecia | Phase 1 | Status: COMPLETED